ARVN Stock Analysis: Buy, Sell, or Hold?
ARVN - Arvinas, Inc
$13.38
0.00 (0.00%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
9d
Get Alerted When ARVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ARVN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ARVN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ARVN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ARVN is currently trading at $13.38, which is considered extended relative to its 30-day fair value range of $11.74 to $12.93.
Technical Outlook: Technically, ARVN is in a strong uptrend. The price is approaching resistance at $13.71. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARVN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARVN is in a strong uptrend. The price is approaching resistance at $13.71. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARVN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$11.74 -
$12.93
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($12.81)
Fair Price Analysis
30-Day Fair Range
$11.74 -
$12.93
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$0.88
(6.6%)
Support & Resistance Levels
Support Level
$11.82
Resistance Level
$13.71
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.55
Wall Street Target
$12.81
(-4.2%)
Revenue Growth (YoY)
-59.1%
Profit Margin
-18.7%
Last updated: January 31, 2026 3:02 PM ET
Data refreshes hourly during market hours. Next update: 4:02 PM
Data refreshes hourly during market hours. Next update: 4:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARVN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Briggs Morrison
BUY
30000 shares
2025-09-22
Featured in Portfolios
ARVN is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced ARVN Option Strategies
Professional options setups generated by AI based on today's ARVN price and gamma walls.
